Tisagenlecleucel

SKU: orb1943782

Description

Tisagenlecleucel (CTL019) is an autologous CAR T-cell therapy designed to target and eliminate CD19-positive B cells. It is used in research models to study refractory aggressive diffuse large B-cell lymphoma, with applications in both in vitro cytotoxicity assays and in vivo preclinical studies.

Research Area

Immunology & Inflammation

Images & Validation

−

Key Properties

−

Target	Immunology/Inflammation related

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol

Immunology/Inflammation related

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols